Semaglutide Medical Weight Loss

Service Description

Prescription Medical Weight Loss Semaglutide and Tirzepatide once weekly demonstrated up to a 20% weight loss. In the case of Tirzepatide, over 85% of participants over 72 weeks in the SURMOUNT-1 trial supported by Eli Lilly lost 20% of their baseline weight. Tirzepatide works by improving the body's sensitivity to insulin, reducing hunger and stabilizing glucagon levels to achieve gradual sustainable weight loss. A Healthy Generation's One Step Medical Weight Loss Program 1) Initial consultation: Review your medical and family history, lifestyle, weight goals and to establish your plan for weight loss. 2) Follow up appointment: Renew prescriptions, review progress and provide guidance to enhance your weight loss and optimize nutrition with micronutrients to supercharge and sustain weight loss. Notices: Exclusions Apply - Medical weight loss prescriptions with Semaglutide and Tirzepatide will not be prescribed for patients with Type 1 Diabetes, a personal or family history of thyroid cancer, a BMI < 27, and if other contradictions are present such as medication interactions. Weight loss results vary and are not guaranteed. Tirzepatide for obesity and weight management is off label and not currently FDA approved for weight loss.